Address: Energieweg 1, 3641 RT, Mijdrecht,Netherlands
Tel: +31 297 28 06 66
Web: http://www.bayer.nl/ebbsc/cms/nl/index.html
Bayer’s presence in the Netherlands segments Bayer HealthCare, Bayer CropScience and Bayer MaterialScience. The main markets for Bayer products in the Netherlands are health, agriculture, construction and automotive industries. The three segments in our land will yield about 500 million euros in turnover of the parent group and employs around 600 people.
Bayer HealthCare’s aim is to human and animal health promotion. With innovative products, we are improving the welfare and quality of life by diagnosing, preventing and treating diseases.
Bayer HealthCare comprises four divisions. Bayer Shering Pharma, Animal Health, Consumer Care and Diabetes Care. There are more than 53,400 people work for Bayer HealthCare.
The business units of the division Bayer Schering Pharma – General Medicine, Specialized Therapeutics, Hematology / Oncology, Diagnostic Imaging – have medicines to treat diseases such as cancer, cardiovascular diseases, infections, immune and metabolic disorders, multiple sclerosis. There are also funds for contraception, erectile problems and products for imaging (contrast media).
WFIA is quite a remarkable organisation that has been, since its inception ten years ago, reporting very good results. The annual results last week showed another strong focus on the…
The Netherlands is famous throughout Europe and the global pharmaceutical community for its research infrastructure – institutes, university hospitals, and public private partnerships. Given this foundation and the size of…
Given the peculiarities of the pharmaceutical industry in the Netherlands, such as the highest generics penetration rate in Europe, a relatively small manufacturing presence and a considerably regulated market, what…
2010 was a very important year for Ferring as it marks the 60th anniversary of the company’s founding. Amongst the various commemorations this year and in hearing the collective experiences…
The Dutch affiliate of Chiesi was established in 2007 when many changes were occurring in the local industry. The new healthcare system policy went into effect and the market was…
Agendia has experienced remarkable growth in the seven years since you founded the company. In 2009 you expanded the company’s Amsterdam facilities and, in 2010, you doubled the size of…
Founded in 1997 Actelion is certainly the “new kid on the block” when compared to some of the much older mainstays in the pharmaceutical industry. What would you say was…
A very strong phrase that we recently came across describes a “war going on in the generics industry” as a result of the preference policy, which people have claimed has…
Bioceros was founded as a service company built on the immunology expertise of its founders. Additional cell line expertise was added when you joined in 2007. What made this combination…
Clearly the end of 2010 was an exciting time for you. As you entered the transition period as the new CEO of OctoPlus, you also participated in the equity raising.…
As the founder of the Institute of Young Entrepreneurs at the Delft University of Technology and an enthusiastic promoter of innovation and new technologies, what do you believe distinguishes a…
We do not often meet companies that have been successful at retaining their manufacturing facilities in the Netherlands. How and why did former Katwijk Farma -and now Apotex- succeed to…
See our Cookie Privacy Policy Here
